Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
about
In silico modeling of the molecular interactions of antacid medication with the endothelium: novel therapeutic implications in head and neck carcinomas.A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway.The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
P2860
Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@ast
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@en
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@nl
type
label
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@ast
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@en
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@nl
prefLabel
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@ast
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@en
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@nl
P2093
P2860
P356
P1476
Inactivation of cytochrome P45 ...... ne-containing anticancer drug.
@en
P2093
Christine Medower
Haoming Zhang
Hsia-lien Lin
Paul F Hollenberg
William W Johnson
P2860
P304
P356
10.1124/DMD.110.034074
P577
2010-11-10T00:00:00Z